Endocrinology, Vol 127, 440-452, Copyright © 1990 by Endocrine Society

ARTICLES

Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages

EL Webster, DE Tracey, MA Jutila, SA Wolfe Jr and EB De Souza
Laboratory of Neurobiology, National Institute on Drug Abuse, Baltimore, Maryland 21224.

CRF is a primary integrator of the organism's coordinated neuroendocrine, autonomic, behavioral, and immune responses to stress. In the present study the identity of the cell type(s) expressing CRF receptors in mouse spleen was determined using a combination of cell fractionation and receptor-binding techniques. Autoradiographic studies of the distribution of [125I]Tyro-ovine CRF [( 125I]oCRF)-binding sites in spleen localized CRF receptors primarily to the red pulp and marginal zones. The distribution pattern of [125I]oCRF-binding sites closely resembled the pattern of India ink accumulated in phagocytic cells in the same sections. To identify the specific cell type(s) expressing CRF receptors, [125I]oCRF-binding activity was evaluated in splenic cell populations fractionated on the basis of their physical and functional properties. Macrophages were identified in each fraction by their phagocytosis of polystyrene beads and membrane labeling with MONTS-4, a monoclonal antibody specific for resident macrophages. Spleen cells were fractionated by adherence to glass bead or Sephadex G- 10 columns, phagocytosis of carbonyl iron particles, and centrifugation on discontinuous Percoll gradients. By all fractionation methods, there was a significant correlation of [125I]oCRF binding with both phagocytic activity (r = 0.75; P less than 0.001) and MONTS-4 staining (r = 0.84; P less than 0.001), strongly suggesting that CRF receptors are primarily expressed on resident splenic macrophages. However, there was essentially no specific binding of [125I]oCRF to either resident or elicited peritoneal macrophages or to several monocyte/macrophage, B- cell, or T-cell lines. While these results suggest that the expression of CRF receptors may be restricted to a population of splenic macrophages, they do not exclude the possibility that CRF receptors may be induced on resident macrophages in spleen and other immune system- related tissues by factors present in the microenvironment.

This article has been cited by other articles:

				C. Tsatsanis, A. Androulidaki, T. Alissafi, I. Charalampopoulos, E. Dermitzaki, T. Roger, A. Gravanis, and A. N. Margioris Corticotropin-Releasing Factor and the Urocortins Induce the Expression of TLR4 in Macrophages via Activation of the Transcription Factors PU.1 and AP-1 J. Immunol., February 1, 2006; 176(3): 1869 - 1877. [Abstract] [Full Text] [PDF]

				N. G Papadopoulou, L. Oleson, D. Kempuraj, J. Donelan, C. L Cetrulo, and T. C Theoharides Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells J. Mol. Endocrinol., December 1, 2005; 35(3): R1 - R8. [Abstract] [Full Text] [PDF]

				J. Cao, N. Papadopoulou, D. Kempuraj, W. S. Boucher, K. Sugimoto, C. L. Cetrulo, and T. C. Theoharides Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor J. Immunol., June 15, 2005; 174(12): 7665 - 7675. [Abstract] [Full Text] [PDF]

				S. Agelaki, C. Tsatsanis, A. Gravanis, and A. N. Margioris Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice Infect. Immun., November 1, 2002; 70(11): 6068 - 6074. [Abstract] [Full Text] [PDF]

				J. Zhao and K. P. Karalis Regulation of Nuclear Factor-{kappa}B by Corticotropin-Releasing Hormone in Mouse Thymocytes Mol. Endocrinol., November 1, 2002; 16(11): 2561 - 2570. [Abstract] [Full Text] [PDF]

				M. Kohno, Y. Kawahito, Y. Tsubouchi, A. Hashiramoto, R. Yamada, K.-i. Inoue, Y. Kusaka, T. Kubo, I. J. Elenkov, G. P. Chrousos, et al. Urocortin Expression in Synovium of Patients with Rheumatoid Arthritis and Osteoarthritis: Relation to Inflammatory Activity J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4344 - 4352. [Abstract] [Full Text] [PDF]

				S. R. Smith, L. de Jonge, M. Pellymounter, T. Nguyen, R. Harris, D. York, S. Redmann, J. Rood, and G. A. Bray Peripheral Administration of Human Corticotropin-Releasing Hormone: A Novel Method to Increase Energy Expenditure and Fat Oxidation in Man J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1991 - 1998. [Abstract] [Full Text]

				C. J. Rossant, R. D. Pinnock, J. Hughes, M. D. Hall, and S. McNulty Corticotropin-Releasing Factor Type 1 and Type 2{alpha} Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase Endocrinology, April 1, 1999; 140(4): 1525 - 1536. [Abstract] [Full Text]

				M. Radulovic, F. M. Dautzenberg, S. Sydow, J. Radulovic, and J. Spiess Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells J. Immunol., March 1, 1999; 162(5): 3013 - 3021. [Abstract] [Full Text] [PDF]

				R. J. Woods, C. F. Kemp, J. David, and P. J. Lowry Heterogeneity of the Human Corticotropin-Releasing Factor-Binding Protein J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1566 - 1571. [Abstract] [Full Text] [PDF]

				K Karalis, H Sano, J Redwine, S Listwak, R. Wilder, and G. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science, October 18, 1991; 254(5030): 421 - 423. [Abstract] [PDF]